{"id":"https://openalex.org/W1977776342","doi":"https://doi.org/10.1186/1471-2164-14-898","title":"Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer","display_name":"Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer","publication_year":2013,"publication_date":"2013-12-01","ids":{"openalex":"https://openalex.org/W1977776342","doi":"https://doi.org/10.1186/1471-2164-14-898","mag":"1977776342","pmid":"https://pubmed.ncbi.nlm.nih.gov/24344919","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3878566"},"language":"en","primary_location":{"id":"doi:10.1186/1471-2164-14-898","doi":"https://doi.org/10.1186/1471-2164-14-898","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2164-14-898","pdf_url":"https://bmcgenomics.biomedcentral.com/counter/pdf/10.1186/1471-2164-14-898","source":{"id":"https://openalex.org/S28614077","display_name":"BMC Genomics","issn_l":"1471-2164","issn":["1471-2164"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Genomics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmcgenomics.biomedcentral.com/counter/pdf/10.1186/1471-2164-14-898","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057879270","display_name":"Rui Henrique","orcid":"https://orcid.org/0000-0003-3171-4666","observed_orcids":["https://orcid.org/0000-0003-3171-4666"]},"institutions":[{"id":"https://openalex.org/I182534213","display_name":"Universidade do Porto","ror":"https://ror.org/043pwc612","country_code":"PT","type":"education","lineage":["https://openalex.org/I182534213"]},{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]},{"id":"https://openalex.org/I4405263123","display_name":"Instituto de Ci\u00eancias Biom\u00e9dicas Albel Salazar","ror":"https://ror.org/02trb6b02","country_code":"PT","type":"education","lineage":["https://openalex.org/I182534213","https://openalex.org/I4405263123"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Rui Henrique","raw_affiliation_strings":["Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto, Largo Prof. Abel Salazar 2, 4099-003, Porto, Portugal","Department of Pathology, Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210103180","https://openalex.org/I4210111164"]},{"raw_affiliation_string":"Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto, Largo Prof. Abel Salazar 2, 4099-003, Porto, Portugal","institution_ids":["https://openalex.org/I182534213","https://openalex.org/I4405263123"]},{"raw_affiliation_string":"Department of Pathology, Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210111164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083321170","display_name":"Ana Isabel Oliveira","orcid":"https://orcid.org/0000-0002-3160-6596","observed_orcids":["https://orcid.org/0000-0002-3160-6596"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Ana Isabel Oliveira","raw_affiliation_strings":["Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210103180","https://openalex.org/I4210111164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026140052","display_name":"Vera L. Costa","orcid":"https://orcid.org/0000-0003-0801-2113","observed_orcids":["https://orcid.org/0000-0003-0801-2113"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Vera L Costa","raw_affiliation_strings":["Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210103180","https://openalex.org/I4210111164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021465666","display_name":"Tiago Baptista","orcid":"https://orcid.org/0000-0003-3196-8308","observed_orcids":["https://orcid.org/0000-0003-3196-8308"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Tiago Baptista","raw_affiliation_strings":["Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210103180","https://openalex.org/I4210111164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089484660","display_name":"Ana Teresa Martins","orcid":"https://orcid.org/0000-0003-4045-6099","observed_orcids":["https://orcid.org/0000-0003-4045-6099"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Ana Teresa Martins","raw_affiliation_strings":["Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","Department of Pathology, Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210103180","https://openalex.org/I4210111164"]},{"raw_affiliation_string":"Department of Pathology, Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210111164"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ant\u00f3nio Morais","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Ant\u00f3nio Morais","raw_affiliation_strings":["Department of Urology, Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210103180","https://openalex.org/I4210111164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001156104","display_name":"Jorge Oliveira","orcid":"https://orcid.org/0000-0001-7838-7493","observed_orcids":["https://orcid.org/0000-0001-7838-7493"]},"institutions":[{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I4210111164","display_name":"IPO Porto","ror":"https://ror.org/027ras364","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210111164"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Jorge Oliveira","raw_affiliation_strings":["Department of Urology, Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Portuguese Oncology Institute, Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072, Porto, Portugal","institution_ids":["https://openalex.org/I4210103180","https://openalex.org/I4210111164"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042199157","display_name":"C\u00e1rmen Jer\u00f3nimo","orcid":"https://orcid.org/0000-0003-4186-5345","observed_orcids":["https://orcid.org/0000-0003-4186-5345"]},"institutions":[{"id":"https://openalex.org/I182534213","display_name":"Universidade do Porto","ror":"https://ror.org/043pwc612","country_code":"PT","type":"education","lineage":["https://openalex.org/I182534213"]},{"id":"https://openalex.org/I4210103180","display_name":"Instituto Portugu\u00eas de Oncologia Francisco Gentil","ror":"https://ror.org/00r7b5b77","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210103180"]},{"id":"https://openalex.org/I4405256639","display_name":"Centro de Investiga\u00e7\u00e3o do Instituto Portugu\u00eas de Oncologia do Porto Francisco Gentil","ror":"https://ror.org/04cxp0t61","country_code":"PT","type":"facility","lineage":["https://openalex.org/I4210103180","https://openalex.org/I4405256639"]},{"id":"https://openalex.org/I4405263123","display_name":"Instituto de Ci\u00eancias Biom\u00e9dicas Albel Salazar","ror":"https://ror.org/02trb6b02","country_code":"PT","type":"education","lineage":["https://openalex.org/I182534213","https://openalex.org/I4405263123"]}],"countries":["PT"],"is_corresponding":true,"raw_author_name":"Carmen Jer\u00f3nimo","raw_affiliation_strings":["Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute, Porto, Rua Dr, Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal. carmenjeronimo@ipoporto.min-saude.pt","Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto, Largo Prof. Abel Salazar 2, 4099-003, Porto, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute, Porto, Rua Dr, Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal. carmenjeronimo@ipoporto.min-saude.pt","institution_ids":["https://openalex.org/I4210103180","https://openalex.org/I4405256639"]},{"raw_affiliation_string":"Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto, Largo Prof. Abel Salazar 2, 4099-003, Porto, Portugal","institution_ids":["https://openalex.org/I182534213","https://openalex.org/I4405263123"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5042199157"],"corresponding_institution_ids":["https://openalex.org/I182534213","https://openalex.org/I4210103180","https://openalex.org/I4405256639","https://openalex.org/I4405263123"],"apc_list":{"value":3090,"currency":"USD","value_usd":3090},"apc_paid":{"value":3090,"currency":"USD","value_usd":3090},"fwci":2.6213,"has_fulltext":true,"cited_by_count":74,"citation_normalized_percentile":{"value":0.91414192,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"14","issue":"1","first_page":"898","last_page":"898"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.8978999853134155,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.8978999853134155,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.05249999836087227,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.03449999913573265,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mdr1","display_name":"MDR1","score":0.8569999933242798},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9649999737739563},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9210000038146973},{"id":"https://openalex.org/keywords/epigenetic-regulation","display_name":"epigenetic regulation","score":0.7649999856948853},{"id":"https://openalex.org/keywords/promoter-methylation","display_name":"promoter methylation","score":0.8059999942779541},{"id":"https://openalex.org/keywords/histone-modifications","display_name":"histone modifications","score":0.8579999804496765},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibition","display_name":"histone deacetylase inhibition","score":0.7889999747276306},{"id":"https://openalex.org/keywords/trichostatin-a","display_name":"trichostatin A","score":0.9679999947547913},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":0.9570000171661377},{"id":"https://openalex.org/keywords/prostatic-intraepithelial-neoplasia","display_name":"prostatic intraepithelial neoplasia","score":0.9729999899864197},{"id":"https://openalex.org/keywords/histone-acetylation","display_name":"histone acetylation","score":0.7739999890327454},{"id":"https://openalex.org/keywords/histone-methylation","display_name":"histone methylation","score":0.8700000047683716}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.7253819704055786},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.6843051910400391},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.6756638884544373},{"id":"https://openalex.org/C2777865847","wikidata":"https://www.wikidata.org/wiki/Q425894","display_name":"Trichostatin A","level":5,"score":0.6294616460800171},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5763247013092041},{"id":"https://openalex.org/C33288867","wikidata":"https://www.wikidata.org/wiki/Q518328","display_name":"Methylation","level":3,"score":0.566859781742096},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.5573421120643616},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5394120812416077},{"id":"https://openalex.org/C91965660","wikidata":"https://www.wikidata.org/wiki/Q415875","display_name":"Methyltransferase","level":4,"score":0.5359113812446594},{"id":"https://openalex.org/C50171091","wikidata":"https://www.wikidata.org/wiki/Q17917770","display_name":"EZH2","level":4,"score":0.5129051208496094},{"id":"https://openalex.org/C150425827","wikidata":"https://www.wikidata.org/wiki/Q2560317","display_name":"Histone methyltransferase","level":4,"score":0.43322306871414185},{"id":"https://openalex.org/C165864922","wikidata":"https://www.wikidata.org/wiki/Q411391","display_name":"Regulation of gene expression","level":3,"score":0.42691928148269653},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.426890105009079},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.42276597023010254},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.36471128463745117},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.23900732398033142},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1885339617729187},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.16413116455078125}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006657","descriptor_name":"Histones","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011401","descriptor_name":"Promoter Regions, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011467","descriptor_name":"Prostate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011499","descriptor_name":"Protein Processing, Post-Translational","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018899","descriptor_name":"CpG Islands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019175","descriptor_name":"DNA Methylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D044127","descriptor_name":"Epigenesis, Genetic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060787","descriptor_name":"Neoplasm Grading","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1186/1471-2164-14-898","doi":"https://doi.org/10.1186/1471-2164-14-898","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2164-14-898","pdf_url":"https://bmcgenomics.biomedcentral.com/counter/pdf/10.1186/1471-2164-14-898","source":{"id":"https://openalex.org/S28614077","display_name":"BMC Genomics","issn_l":"1471-2164","issn":["1471-2164"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Genomics","raw_type":"journal-article"},{"id":"pmid:24344919","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24344919","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC genomics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3878566","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3878566/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Genomics","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1186/1471-2164-14-898","doi":"https://doi.org/10.1186/1471-2164-14-898","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2164-14-898","pdf_url":"https://bmcgenomics.biomedcentral.com/counter/pdf/10.1186/1471-2164-14-898","source":{"id":"https://openalex.org/S28614077","display_name":"BMC Genomics","issn_l":"1471-2164","issn":["1471-2164"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Genomics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4717039289","display_name":"Development of sensitive methodologies for exploitation of early epigenetic marker diagnosis in major types of cancer","funder_award_id":"241783","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"}],"funders":[{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320338377","display_name":"FP7 Health","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1977776342.pdf","grobid_xml":"https://content.openalex.org/works/W1977776342.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W1497498736","https://openalex.org/W1587030064","https://openalex.org/W1774630295","https://openalex.org/W1831451634","https://openalex.org/W1968931590","https://openalex.org/W1974039662","https://openalex.org/W1981989535","https://openalex.org/W1982858970","https://openalex.org/W1990236447","https://openalex.org/W1998118468","https://openalex.org/W2004385163","https://openalex.org/W2021459974","https://openalex.org/W2021860894","https://openalex.org/W2026431475","https://openalex.org/W2029197798","https://openalex.org/W2033267649","https://openalex.org/W2037760823","https://openalex.org/W2038700261","https://openalex.org/W2064838548","https://openalex.org/W2075174542","https://openalex.org/W2076234267","https://openalex.org/W2082594247","https://openalex.org/W2089689396","https://openalex.org/W2090017867","https://openalex.org/W2095682420","https://openalex.org/W2106787323","https://openalex.org/W2109264608","https://openalex.org/W2115314035","https://openalex.org/W2118937378","https://openalex.org/W2123002505","https://openalex.org/W2153487848","https://openalex.org/W2153680571","https://openalex.org/W2161012076","https://openalex.org/W2162665020","https://openalex.org/W2163205674","https://openalex.org/W2163454545","https://openalex.org/W2312409531","https://openalex.org/W2403689221","https://openalex.org/W2406054717","https://openalex.org/W2414305690","https://openalex.org/W2512454832","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2153487848","https://openalex.org/W2074803927","https://openalex.org/W2349863590","https://openalex.org/W2085824187","https://openalex.org/W2148053857","https://openalex.org/W2968913047","https://openalex.org/W2267746463","https://openalex.org/W2007390885","https://openalex.org/W2161767853","https://openalex.org/W2100999040"],"abstract_inverted_index":{"BACKGROUND:":[0],"Multidrug":[1],"resistance":[2],"1":[3],"(MDR1)":[4],"gene":[5],"encodes":[6],"for":[7],"an":[8,29],"ATP":[9],"binding":[10],"cassette":[11],"transporter--P-glycoprotein":[12],"(P-gp)--":[13],"involved":[14,46],"in":[15,24,47,50,61,148,180,221],"chemoresistance":[16],"to":[17,41,96,135,138,158,184,209,229],"taxanes.":[18],"MDR1":[19,48,53,125,205,224],"promoter":[20,54,126,206,238],"methylation":[21,55,85,127,155,165],"is":[22,226],"frequent":[23],"prostate":[25,79,222],"carcinoma":[26],"(PCa),":[27],"suggesting":[28],"epigenetic":[30,44],"regulation":[31],"but":[32],"no":[33],"functional":[34],"correlation":[35],"has":[36],"been":[37],"established.":[38],"We":[39],"aimed":[40],"elucidate":[42],"the":[43,204,241],"mechanisms":[45],"deregulation":[49],"PCa.":[51,139],"RESULTS:":[52],"and":[56,75,88,103,111,118,122,129,137,150,175,199],"P-gp":[57,144,173,244],"expression":[58,169],"were":[59,94,116,178,201],"assessed":[60],"121":[62],"PCa,":[63,151],"39":[64],"high-grade":[65],"prostatic":[66,72],"intraepithelial":[67],"neoplasia":[68],"(HGPIN),":[69],"28":[70],"benign":[71],"hyperplasia":[73],"(BPH)":[74],"10":[76],"morphologically":[77],"normal":[78],"tissue":[80],"(NPT)":[81],"samples,":[82],"using":[83],"quantitative":[84],"specific":[86],"PCR":[87],"immunohistochemistry,":[89],"respectively.":[90],"PCa":[91],"cell":[92,181],"lines":[93,182],"exposed":[95,183],"a":[97],"DNA":[98],"methyltransferases":[99],"inhibitor":[100,106],"5-aza-2'deoxycytidine":[101],"(DAC)":[102],"histone":[104,112,192,230],"deacetylases":[105],"trichostatin":[107],"A":[108],"(TSA).":[109],"Methylation":[110],"posttranscriptional":[113],"modifications":[114],"status":[115],"characterized":[117],"correlated":[119],"with":[120,154,189,214,236,243],"mRNA":[121,174],"protein":[123,176],"expression.":[124,246],"levels":[128],"frequency":[130],"significantly":[131,164],"increased":[132,168,202],"from":[133],"NPTs,":[134],"HGPIN":[136,149],"Conversely,":[140],"decreased":[141,245],"or":[142,187,212],"absent":[143],"immunoexpression":[145],"was":[146,170],"observed":[147],"inversely":[152],"correlating":[153],"levels.":[156],"Exposure":[157],"DAC":[159],"alone":[160,186,211],"did":[161],"not":[162],"alter":[163],"levels,":[166],"although":[167],"apparent.":[171],"However,":[172],"re-expression":[177],"higher":[179],"TSA":[185,210],"combined":[188,213],"DAC.":[190,215],"Accordingly,":[191],"active":[193],"marks":[194],"H3Ac,":[195],"H3K4me2,":[196],"H3K4me3,":[197],"H3K9Ac,":[198],"H4Ac":[200],"at":[203],"after":[207],"exposure":[208],"CONCLUSION:":[216],"Our":[217],"data":[218],"suggests":[219],"that,":[220],"carcinogenesis,":[223],"downregulation":[225],"mainly":[227],"due":[228],"post-translational":[231],"modifications.":[232],"This":[233],"occurs":[234],"concomitantly":[235],"aberrant":[237],"methylation,":[239],"substantiating":[240],"association":[242]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":7}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}